OTC · Biotechnology

EvoNext Holdings S.A. (ELVAF) Stock

$2.15 +0.00% OTC: ELVAF Healthcare

EvoNext Holdings SA focuses on the discovery, refinement, and market introduction of innovative components for nutritional, healthcare, and general wellness applications. This enterprise was established in 2004 by Alexandra Santana Sørensen, Søren V.

Valuation

MetricValue
Price$2.15
Market Cap$15.50M
P/E Ratio-23.56
P/B Ratio2.58
P/S Ratio0.00
EPS (TTM)$-0.09
52-Week High$2.15
52-Week Low$0.90
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-10.72%
ROA-9.66%
ROCE-11.41%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio8.31

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$16.0M$9.0M$0$0
Operating Profit$-42.0M$-40.0M$-92.0M$1.0M$-1.0M
Net Profit$-41.0M$-43.0M$-105.0M$1.0M$-1.0M
EPS$-11.72$-10.13$-19.50$0.14$-0.09
Op Margin-425.5%-259.9%-977.4%——

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$156.0M$131.0M$10.0M$8.0M$7.0M
Total Liabilities$24.0M$25.0M$4.0M$1.0M$1.0M
Cash$11.0M$5.0M$6.0M$7.0M$6.0M
Borrowings$11.0M$15.0M$0$0$0

Latest News

Canadian Investment Regulatory Organization Trade Resumption - FG CNW Group · Jul 30, 2026 TeraWulf stock jumps 20% after landing $19 billion Anthropic AI deal GuruFocus.com · Jul 30, 2026 Delay is Unacceptable | Petrus Recommends Shareholders Not to Tender at €14.10 per Share PR Newswire · Jul 30, 2026 Amazon's AI Sees What It Doesn't Flag GuruFocus.com · Jul 30, 2026 IDrive® e2 Launches MCP Support for Secure AI Access to Cloud Object Storage PR Newswire · Jul 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-30.0M$-19.0M$-9.0M$-2.0M—
Investing Cash Flow$-8.0M$-4.0M$15.0M$7.0M—
Financing Cash Flow$19.0M$9.0M$-1.0M$0—
Net Cash Flow$-9.0M$-6.0M$1.0M$1.0M—
Free Cash Flow$-34.0M$-21.0M$-10.0M$-2.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.10
EV / EBITDA-26.55
FCF Yield-7.44%
Quick Ratio8.31
Interest Coverage-54.27
Return 1Y138.89%
Return 3Y-54.83%
Return 5Y—

Ownership

Insiders Held41.00%
Institutions Held2.62%
Institutions Float Held4.44%
Institutional HolderSharesReport Date
DFA Investment Dimensions-DFA International Social Core Equity Port892023-07-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AVCNFAvicanna Inc. $0.10 +4.32% -4.25 $12.15M 0.00%
BBIXFBonus Biogroup Ltd. $0.10 +0.00% -25.29 $110.95M 0.00%
CLYYFCelyad Oncology S.A. $0.20 +0.00% 14.03 $8.95M 0.00%
FNCHFinch Therapeutics Group, Inc. $9.60 -3.71% -1.11 $15.42M 0.00%
HSITFHadasit Bio-Holdings Ltd $0.12 +0.00% -4.57 $1.33M 0.00%

About EvoNext Holdings S.A.

EvoNext Holdings SA focuses on the discovery, refinement, and market introduction of innovative components for nutritional, healthcare, and general wellness applications. This enterprise was established in 2004 by Alexandra Santana Sørensen, Søren V. S. Nielsen, and Neil Goldsmith, and maintains its primary base of operations in Reinach, Switzerland.

EvoNext Holdings S.A. is headquartered in CH.

EvoNext Holdings S.A. (ELVAF) stock trades at $2.15 with a market capitalization of $15.50M. The stock is valued at a price-to-earnings (P/E) ratio of -23.56, price-to-book of 2.58, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.90 and $2.15, and currently trades at its 52-week high.

On profitability, EvoNext Holdings S.A. generates a return on equity (ROE) of -10.72%, return on capital employed of -11.41%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: evonextholdings.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides